146 related articles for article (PubMed ID: 2551544)
1. Endogenous inhibition of red blood cell Na,K-ATPase in essential and pregnancy-induced hypertension.
Ringel R; Pinkas G; Hamlyn J; Mullins L; Hamilton B
Clin Exp Hypertens A; 1989; 11(4):587-601. PubMed ID: 2551544
[TBL] [Abstract][Full Text] [Related]
2. Ouabain-like Na+,K(+)-ATPase inhibitory activity of a plasma extract in normal pregnancy and pregnancy induced hypertension.
Miyagi H; Higuchi M; Nakayama M; Moromizato H; Sakanashi M
Jpn J Pharmacol; 1991 Dec; 57(4):571-81. PubMed ID: 1666421
[TBL] [Abstract][Full Text] [Related]
3. Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction.
Bagrov AYa ; Fedorova OV; Maslova MN; Roukoyatkina NI; Ukhanova MV; Zhabko EP
Cardiovasc Res; 1991 May; 25(5):371-7. PubMed ID: 1649699
[TBL] [Abstract][Full Text] [Related]
4. Alteration in ouabain-sensitive sodium potassium pump of erythrocytes during pregnancy induced hypertension: a kinetic study.
Kaur G; Kapoor N; Mohan P; Sri Nageswari K; Singh MJ; Prasad R
J Biochem Mol Biol Biophys; 2002 Jun; 6(3):163-6. PubMed ID: 12186749
[TBL] [Abstract][Full Text] [Related]
5. Altered Na(+)-K+ ATPase activity in uraemic adolescents.
Vásárhelyi B; Sallay P; Balog E; Reusz G; Tulassay T
Acta Paediatr; 1996 Aug; 85(8):919-22. PubMed ID: 8863871
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte Na+, K+-ATPase and serum digoxin concentrations.
From AH; Quarfoth GJ; Steele BW; Ahmed K
Eur J Clin Pharmacol; 1983; 24(6):807-12. PubMed ID: 6309531
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of membrane Na(+)-K+ Atpase of the brain, liver and RBC in rats administered di(2-ethyl hexyl) phthalate (DEHP) a plasticizer used in polyvinyl chloride (PVC) blood storage bags.
Dhanya CR; Indu AR; Deepadevi KV; Kurup PA
Indian J Exp Biol; 2003 Aug; 41(8):814-20. PubMed ID: 15248477
[TBL] [Abstract][Full Text] [Related]
8. Serum digoxin-like substances in pregnancy-induced hypertension.
Poston L; Morris JF; Wolfe CD; Hilton PJ
Clin Sci (Lond); 1989 Aug; 77(2):189-94. PubMed ID: 2548800
[TBL] [Abstract][Full Text] [Related]
9. Erythrocyte Na,K pump activity and arterial hypertension in uremic dialyzed patients.
Boero R; Guarena C; Berto IM; Deabate MC; Rosati C; Quarello F; Piccoli G
Kidney Int; 1988 Nov; 34(5):691-6. PubMed ID: 2848975
[TBL] [Abstract][Full Text] [Related]
10. Abnormal membrane cation transport in pregnancy-induced hypertension.
Testa I; Rabini RA; Danieli G; Tranquilli AL; Cester N; Romanini C; Bertoli E; Mazzanti L
Scand J Clin Lab Invest; 1988 Feb; 48(1):7-13. PubMed ID: 2851165
[TBL] [Abstract][Full Text] [Related]
11. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
[TBL] [Abstract][Full Text] [Related]
12. Red blood cell Na+,K+-ATPase in men with newly diagnosed or previously treated essential hypertension.
Ringel RE; Hamlyn JM; Hamilton BP; Pinkas GA; Chalew SA; Berman MA
Hypertension; 1987 May; 9(5):437-43. PubMed ID: 3032788
[TBL] [Abstract][Full Text] [Related]
13. Further evidence for the dissociation of digoxin-like immunoreactivity from Na+,K(+)-ATPase inhibitory activity.
Yamada K; Goto A; Ishii M; Yoshioka M; Sugimoto T
Experientia; 1990 Oct; 46(10):1041-3. PubMed ID: 2171976
[TBL] [Abstract][Full Text] [Related]
14. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
[TBL] [Abstract][Full Text] [Related]
15. Studies on the role of sodium- and potassium-activated adenosine triphosphatase inhibition in the pathogenesis of human hypertension. Changes in vascular and cardiac function following inhibition of the sodium pump in normotensive subjects and effects of calcium entry blockade.
Kramer HJ; Glänzer K; Freitag T; Schönfeld J; Sorger M; Schlebusch H; Düsing R; Krück F
Klin Wochenschr; 1985 Jan; 63(1):32-6. PubMed ID: 2579261
[TBL] [Abstract][Full Text] [Related]
16. Na,K-atpase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parameters.
Djemli-Shipkolye A; Coste T; Raccah D; Vague P; Pieroni G; Gerbi A
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):297-304. PubMed ID: 11355004
[TBL] [Abstract][Full Text] [Related]
17. [Endogenous digitalis-like substance and Na-K-ATPase inhibitor in cardiovascular and renal disease].
Okamoto S
Nihon Naibunpi Gakkai Zasshi; 1988 Jan; 64(1):39-50. PubMed ID: 2837414
[TBL] [Abstract][Full Text] [Related]
18. Na,K-ATPase from placenta of women with pregnancy-induced hypertension exhibits an increased affinity for cardiac glycosides.
Amler E; Cester N; Magnanelli R; Mazzanti L; Kotyk A; Romanini C
Physiol Res; 1994; 43(1):33-6. PubMed ID: 8054335
[TBL] [Abstract][Full Text] [Related]
19. [The activity and properties of Na,K-ATPase in the erythrocytes and the Na-pump inhibitor in the plasma of subjects with borderline arterial hypertension].
Maslova MN; Ogorodnikova LE; Titkov IuS
Fiziol Zh SSSR Im I M Sechenova; 1991 Sep; 77(9):232-7. PubMed ID: 1666609
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte membrane digoxin-sensitive (Na(+)-K+)-ATPase of non-insulin dependent diabetic humans.
Okegbile EO; Odusan O; Adeola O
Biosci Rep; 1997 Oct; 17(5):499-506. PubMed ID: 9419391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
